New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Skip to main content
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / Virginia

Peptide legality · Virginia · updated 2026-09-21

Are peptides legal in Virginia?

Gray area

In Virginia, peptides are legal only within the federal compounding framework, so brand-name GLP-1 medicines are fully legal by prescription while compounded and research peptides sit in a gray zone with rising enforcement.

Legal status overview

Virginia permits peptides only within the federal compounding framework, so brand-name GLP-1 medicines are legal by prescription while compounded and research peptides remain in a gray zone. The Virginia Board of Pharmacy, part of the Department of Health Professions, has not issued a peptide-specific rule and relies on the federal floor set by the FDA and sections 503A and 503B. Compounded semaglutide can still be prepared for a documented patient-specific clinical reason, but routine copies of Wegovy® (semaglutide) ended after the FDA declared the shortage resolved in February 2025. Research peptides such as BPC-157 and TB-500 are unscheduled but not FDA-approved, and state enforcement against high-volume telehealth weight-loss operations has increased. This is information, not medical or legal advice.

Key points

  • The Virginia Board of Pharmacy has not published a peptide-specific rule, so pharmacies follow the federal compounding floor set by the FDA and sections 503A and 503B. [3]
  • Wegovy® (semaglutide) and Zepbound® (tirzepatide) are FDA-approved and legal to prescribe in Virginia; only the compounded and research versions raise legality questions. [1]
  • After the FDA resolved the semaglutide shortage in February 2025, 503A pharmacies may compound semaglutide only for a documented patient-specific clinical reason such as an allergy or a needed dosage form. [6]
  • Compounded semaglutide is not FDA-approved, is not a generic, and has not been evaluated by the FDA. [1]
  • A telehealth provider must be licensed in the state where the patient is located, so a Virginia patient generally needs a Virginia-licensed prescriber. [6]
  • BPC-157 is not a controlled substance in Virginia and was removed from FDA Category 2 in April 2026, but it is not FDA-approved and not yet permitted for compounding pending final rulemaking. [4]
  • Enforcement against high-volume telehealth weight-loss shops and bulk-stocked compounded semaglutide has risen sharply nationally, a trend that reaches Virginia providers. [6]

Compound-by-compound status

BPC-157
Gray area
Not a controlled substance and not FDA-approved; removed from 503A Category 2 in April 2026 and recommended for 503A in July 2026, but not yet permitted for compounding pending final FDA rulemaking.
GLP-1 class: Wegovy® (semaglutide) and Zepbound® (tirzepatide)
Restricted
Branded products are FDA-approved and legal by prescription; compounded semaglutide and tirzepatide are not FDA-approved, are not a generic, and have not been evaluated by the FDA, and are permitted only for a documented patient-specific clinical need after the 2025 shortage resolution.
TB-500 (thymosin beta-4 fragment)
Restricted
Not FDA-approved and not on the permitted 503A bulk substances list; sold only as a research chemical and not authorized for human use.
Growth hormone / somatropin
Restricted
FDA-approved by prescription for defined indications; federal law (21 U.S.C. 333(e)) makes distribution for non-approved uses a crime, so access is tightly restricted.

Frequently asked questions

Is compounded semaglutide legal in Virginia?

It can be legal when a Virginia-licensed prescriber documents a patient-specific clinical reason and a licensed 503A pharmacy prepares it, but routine copies of Wegovy® (semaglutide) ended after the FDA resolved the shortage in February 2025. Compounded semaglutide is not FDA-approved, is not a generic, and has not been evaluated by the FDA.

Is BPC-157 legal in Virginia?

BPC-157 is not a controlled substance in Virginia, but it is not FDA-approved and is not currently permitted for pharmacy compounding, so it remains in a gray zone. Research-use-only products are not authorized for human use.

Does Virginia have a specific peptide statute?

No. The Virginia Board of Pharmacy relies on the federal framework under the FDA and sections 503A and 503B rather than a dedicated peptide rule.

Can I use telehealth for peptides in Virginia?

A telehealth prescriber generally must be licensed where the patient is located, so a Virginia patient needs a Virginia-licensed provider, and any compounded product must still meet federal limits.

Are brand-name GLP-1 drugs legal in Virginia?

Yes. Wegovy® (semaglutide) and Zepbound® (tirzepatide) are FDA-approved and legally prescribed; the uncertainty applies to compounded and research peptides.

General information based on the sourced research above, not legal advice. For a specific situation in Virginia, consult a licensed attorney familiar with pharmaceutical law.

FDA recalls from firms in Virginia

Recall records from firms in this state3
Years covered2022 to 2022
Most serious classificationClass II
Distinct firms1

Firms with the most records

Mckesson Medical-Surgical Inc. Corporate Office (3)

Most recent

FirmCityClassInitiatedReason given
Mckesson Medical-Surgical Inc. Corporate OfficeRichmondClass II2022-04-13cGMP deviations: Temperature abuse

A recall here means the FDA recorded a product being withdrawn by a firm with an address in Virginia. Most involve compounded preparations and the most common reason given is a lack of assurance of sterility. It describes enforcement history, not whether a product is legal to buy in Virginia. Source: openFDA drug enforcement reports, checked 2026-11-09.

More from Peptides.io

Peptide legality in other states

All 50 states are covered. These are the next few alphabetically.